Literature DB >> 24828495

Regulation of ischemic neuronal death by E2F4-p130 protein complexes.

Grace O Iyirhiaro1, Yi Zhang1, Carmen Estey1, Michael J O'Hare1, Farzaneh Safarpour1, Mohammad Parsanejad1, Suzi Wang1, Elizabeth Abdel-Messih1, Steve M Callaghan1, Matthew J During2, Ruth S Slack1, David S Park3.   

Abstract

Inappropriate activation of cell cycle proteins, in particular cyclin D/Cdk4, is implicated in neuronal death induced by various pathologic stresses, including DNA damage and ischemia. Key targets of Cdk4 in proliferating cells include members of the E2F transcription factors, which mediate the expression of cell cycle proteins as well as death-inducing genes. However, the presence of multiple E2F family members complicates our understanding of their role in death. We focused on whether E2F4, an E2F member believed to exhibit crucial control over the maintenance of a differentiated state of neurons, may be critical in ischemic neuronal death. We observed that, in contrast to E2F1 and E2F3, which sensitize to death, E2F4 plays a crucial protective role in neuronal death evoked by DNA damage, hypoxia, and global ischemic insult both in vitro and in vivo. E2F4 occupies promoter regions of proapoptotic factors, such as B-Myb, under basal conditions. Following stress exposure, E2F4-p130 complexes are lost rapidly along with the presence of E2F4 at E2F-containing B-Myb promoter sites. In contrast, the presence of E2F1 at B-Myb sites increases with stress. Furthermore, B-Myb and C-Myb expression increases with ischemic insult. Taken together, we propose a model by which E2F4 plays a protective role in neurons from ischemic insult by forming repressive complexes that prevent prodeath factors such as Myb from being expressed.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apoptosis; Cardiovascular Disease; Cell Biology; Cell Cycle; Cell Death; Cyclin-dependent Kinase (Cdk); E2F Transcription Factor; Hypoxia; Ischemia; Stroke

Mesh:

Substances:

Year:  2014        PMID: 24828495      PMCID: PMC4140295          DOI: 10.1074/jbc.M114.574145

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Expression of the E2F and retinoblastoma families of proteins during neural differentiation.

Authors:  J C Kusek; R M Greene; M M Pisano
Journal:  Brain Res Bull       Date:  2001-01-15       Impact factor: 4.077

2.  E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3.

Authors:  A Giovanni; E Keramaris; E J Morris; S T Hou; M O'Hare; N Dyson; G S Robertson; R S Slack; D S Park
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

3.  The transcription factor E2F1 modulates apoptosis of neurons.

Authors:  S T Hou; D Callaghan; M C Fournier; I Hill; L Kang; B Massie; P Morley; C Murray; I Rasquinha; R Slack; J P MacManus
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

4.  Induction and modulation of cerebellar granule neuron death by E2F-1.

Authors:  M J O'Hare; S T Hou; E J Morris; S P Cregan; Q Xu; R S Slack; D S Park
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

5.  Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.

Authors:  K Hansen; T Farkas; J Lukas; K Holm; L Rönnstrand; J Bartek
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

6.  Attenuation of neurotoxicity in cortical cultures and hippocampal slices from E2F1 knockout mice.

Authors:  T F Gendron; G A Mealing; J Paris; A Lou; A Edwards; S T Hou; J P MacManus; A M Hakim; P Morley
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

7.  E2F4 is essential for normal erythrocyte maturation and neonatal viability.

Authors:  P O Humbert; C Rogers; S Ganiatsas; R L Landsberg; J M Trimarchi; S Dandapani; C Brugnara; S Erdman; M Schrenzel; R T Bronson; J A Lees
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

8.  The Rb-CDK4/6 signaling pathway is critical in neural precursor cell cycle regulation.

Authors:  K L Ferguson; S M Callaghan; M J O'Hare; D S Park; R S Slack
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

9.  Cyclin-dependent kinases as a therapeutic target for stroke.

Authors:  H Osuga; S Osuga; F Wang; R Fetni; M J Hogan; R S Slack; A M Hakim; J E Ikeda; D S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

10.  Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment.

Authors:  D S Park; A Obeidat; A Giovanni; L A Greene
Journal:  Neurobiol Aging       Date:  2000 Nov-Dec       Impact factor: 4.673

View more
  14 in total

1.  The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors.

Authors:  Tianwen Huang; Yasmilde Rodríguez González; Dianbo Qu; En Huang; Farzaneh Safarpour; Eugene Wang; Alvin Joselin; Doo Soon Im; Steve M Callaghan; Wassamon Boonying; Lisa Julian; Sally L Dunwoodie; Ruth S Slack; David S Park
Journal:  J Biol Chem       Date:  2019-04-09       Impact factor: 5.157

2.  Cdc25A Is a Critical Mediator of Ischemic Neuronal Death In Vitro and In Vivo.

Authors:  Grace O Iyirhiaro; Doo Soon Im; Wassamon Boonying; Steve M Callaghan; Matthew J During; Ruth S Slack; David S Park
Journal:  J Neurosci       Date:  2017-06-12       Impact factor: 6.167

3.  Dynamic effects of genetic variation on gene expression revealed following hypoxic stress in cardiomyocytes.

Authors:  Michelle C Ward; Nicholas E Banovich; Abhishek Sarkar; Matthew Stephens; Yoav Gilad
Journal:  Elife       Date:  2021-02-08       Impact factor: 8.140

Review 4.  Neuronal cell cycle: the neuron itself and its circumstances.

Authors:  José M Frade; María C Ovejero-Benito
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians.

Authors:  Ming Zhao; Jian Qin; Hanqi Yin; Yixin Tan; Wei Liao; Qian Liu; Shuangyan Luo; Min He; Gongping Liang; Yajing Shi; Qing Zhang; Wenjun Cai; Guangliang Yin; Yin Zhou; Jing Wang; Mengying Li; Yi Huang; Aiyun Liu; Haijing Wu; Zhiyong Zhang; Qianjin Lu
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

6.  Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.

Authors:  Li-Yun Yang; Chang-Yu He; Xue-Hua Chen; Li-Ping Su; Bing-Ya Liu; Hao Zhang
Journal:  Oncotarget       Date:  2016-07-26

Review 7.  MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis.

Authors:  Julian Musa; Marie-Ming Aynaud; Olivier Mirabeau; Olivier Delattre; Thomas Gp Grünewald
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

8.  An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.

Authors:  Theresa A Koleck; Catherine M Bender; Beth Z Clark; Christopher M Ryan; Puja Ghotkar; Adam Brufsky; Priscilla F McAuliffe; Priya Rastogi; Susan M Sereika; Yvette P Conley
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-03-03

9.  Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury.

Authors:  Taryn G Aubrecht; Alan I Faden; Boris Sabirzhanov; Ethan P Glaser; Brian A Roelofs; Brian M Polster; Oleg Makarevich; Bogdan A Stoica
Journal:  Cell Death Dis       Date:  2018-11-06       Impact factor: 8.469

10.  Upregulation of MicroRNA-128 in the Peripheral Blood of Acute Ischemic Stroke Patients is Correlated with Stroke Severity Partially through Inhibition of Neuronal Cell Cycle Reentry.

Authors:  Ping Liu; Ziping Han; Qingfeng Ma; Tao Liu; Rongliang Wang; Zhen Tao; Guangwen Li; Fangfang Li; Sijia Zhang; Lingzhi Li; Xuming Ji; Haiping Zhao; Yumin Luo
Journal:  Cell Transplant       Date:  2019-04-30       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.